HurstK. S., ByarD. P.: An analysis of the effects of changes from the assigned treatment in a clinical trial of treatment for prostatic cancer. J. Chron. Dis., 26; 311 (1973).
2.
JonssonG., HogbergB.: Treatment of advanced prostatic carcinoma with Estracyt. Scand. J. Urol. & Nephrol., 5; 103–107 (1971).
3.
MuntzingJ., ShuklaS. K., ChuT. M., MittelmannA., MurphyG. P.: Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. Invest. Urol., 12; 65 (1974).
4.
NagelR., KollnC. P.: Treatment of the advanced carcinoma of the prostate with Estramustine Phosphate. Brit. J. Urol., 49; 73–79 (1977).
5.
NilssoT., JonssonG.: Clinical results with Estramustine phosphate (NSC 89199): a comparision of the intravenous and oral preparations. Cancer Cbem. Rep., 59; 229 (1975).
6.
Von HoffD., RozencweigM., SlavikM., MuggiaF.: Estramustine phosphate: a specific chemotherapeutic agent?. J. Urol., 117; 464–467 (1977).
